{"id":"https://openalex.org/W1555039612","doi":"https://doi.org/10.1212/wnl.82.10_supplement.p2.262","title":"Axonal Protective Role of LINGO-1 Blockade in the Visual System: Results From a Study in Rats and Design of a Phase 2 Clinical Trial for BIIB033, an Anti-LINGO-1 Monoclonal Antibody, in Subjects With a First Episode of Acute Optic Neuritis (P2.262)","display_name":"Axonal Protective Role of LINGO-1 Blockade in the Visual System: Results From a Study in Rats and Design of a Phase 2 Clinical Trial for BIIB033, an Anti-LINGO-1 Monoclonal Antibody, in Subjects With a First Episode of Acute Optic Neuritis (P2.262)","publication_year":2014,"publication_date":"2014-04-08","ids":{"openalex":"https://openalex.org/W1555039612","doi":"https://doi.org/10.1212/wnl.82.10_supplement.p2.262","mag":"1555039612"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.82.10_supplement.p2.262","doi":"https://doi.org/10.1212/wnl.82.10_supplement.p2.262","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.82.10_supplement.p2.262","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088163706","display_name":"Diego Cadavid","orcid":"https://orcid.org/0000-0002-5361-3834","observed_orcids":["https://orcid.org/0000-0002-5361-3834"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diego Cadavid","raw_affiliation_strings":["Biogen Idec Cambridge MA United States","1Biogen Idec Cambridge MA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec Cambridge MA United States","institution_ids":["https://openalex.org/I1297540436"]},{"raw_affiliation_string":"1Biogen Idec Cambridge MA United States","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013357095","display_name":"Laura Joan Balcer","orcid":"https://orcid.org/0000-0002-5136-4539","observed_orcids":["https://orcid.org/0000-0002-5136-4539"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Balcer","raw_affiliation_strings":["NYU Langone Medical Center New York NY United States","2NYU Langone Medical Center New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NYU Langone Medical Center New York NY United States","institution_ids":["https://openalex.org/I4210086933"]},{"raw_affiliation_string":"2NYU Langone Medical Center New York NY United States","institution_ids":["https://openalex.org/I4210086933"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031416421","display_name":"Steven L. Galetta","orcid":"https://orcid.org/0000-0003-3781-7324","observed_orcids":["https://orcid.org/0000-0003-3781-7324"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Galetta","raw_affiliation_strings":["NYU Langone Medical Center New York NY United States","2NYU Langone Medical Center New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NYU Langone Medical Center New York NY United States","institution_ids":["https://openalex.org/I4210086933"]},{"raw_affiliation_string":"2NYU Langone Medical Center New York NY United States","institution_ids":["https://openalex.org/I4210086933"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019246084","display_name":"Bing Hu","orcid":"https://orcid.org/0000-0001-8627-5272","observed_orcids":["https://orcid.org/0000-0001-8627-5272","https://orcid.org/0000-0003-3710-3786"]},"institutions":[{"id":"https://openalex.org/I126520041","display_name":"University of Science and Technology of China","ror":"https://ror.org/04c4dkn09","country_code":"CN","type":"education","lineage":["https://openalex.org/I126520041","https://openalex.org/I19820366"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Bing Hu","raw_affiliation_strings":["University of Science and Technology of China Anhui  China","4University of Science and Technology of China Anhui China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Science and Technology of China Anhui  China","institution_ids":["https://openalex.org/I126520041"]},{"raw_affiliation_string":"4University of Science and Technology of China Anhui China","institution_ids":["https://openalex.org/I126520041"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086351103","display_name":"Kwok\u2010Fai So","orcid":"https://orcid.org/0000-0003-4039-4246","observed_orcids":["https://orcid.org/0000-0003-4039-4246"]},"institutions":[{"id":"https://openalex.org/I889458895","display_name":"University of Hong Kong","ror":"https://ror.org/02zhqgq86","country_code":"HK","type":"education","lineage":["https://openalex.org/I889458895"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"Kwok-Fai So","raw_affiliation_strings":["University of Hong Kong Hong Kong  China","#N# 3University of Hong Kong, Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Hong Kong Hong Kong  China","institution_ids":["https://openalex.org/I889458895"]},{"raw_affiliation_string":"#N# 3University of Hong Kong, Hong Kong, China","institution_ids":["https://openalex.org/I889458895"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068013588","display_name":"Blake Pepinksy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Blake Pepinksy","raw_affiliation_strings":["Biogen Idec Cambridge MA United States","1Biogen Idec Cambridge MA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec Cambridge MA United States","institution_ids":["https://openalex.org/I1297540436"]},{"raw_affiliation_string":"1Biogen Idec Cambridge MA United States","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059125322","display_name":"Sha Mi","orcid":"https://orcid.org/0000-0002-4786-6894","observed_orcids":["https://orcid.org/0000-0002-4786-6894"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sha Mi","raw_affiliation_strings":["Biogen Idec Cambridge MA United States","1Biogen Idec Cambridge MA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec Cambridge MA United States","institution_ids":["https://openalex.org/I1297540436"]},{"raw_affiliation_string":"1Biogen Idec Cambridge MA United States","institution_ids":["https://openalex.org/I1297540436"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0660982,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"10_supplement","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10483","display_name":"Nerve injury and regeneration","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lingo-1","display_name":"LINGO-1","score":0.8939999938011169},{"id":"https://openalex.org/keywords/acute-optic-neuritis","display_name":"acute optic neuritis","score":0.9100000262260437},{"id":"https://openalex.org/keywords/axon-regeneration","display_name":"axon regeneration","score":0.972000002861023},{"id":"https://openalex.org/keywords/retinal-ganglion-cells","display_name":"retinal ganglion cells","score":0.8429999947547913},{"id":"https://openalex.org/keywords/remyelination","display_name":"remyelination","score":0.8859999775886536},{"id":"https://openalex.org/keywords/optic-nerve-injury","display_name":"optic nerve injury","score":0.3070000112056732},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.6859999895095825},{"id":"https://openalex.org/keywords/axonal-protection","display_name":"axonal protection","score":0.5580000281333923},{"id":"https://openalex.org/keywords/retinal-nerve-fiber-layer","display_name":"retinal nerve fiber layer","score":0.6010000109672546},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.5979999899864197},{"id":"https://openalex.org/keywords/intravitreal-administration","display_name":"intravitreal administration","score":0.6330000162124634}],"concepts":[{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.670204758644104},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5563691854476929},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5512838363647461},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4712156355381012},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.44653549790382385},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.36441636085510254},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3150045871734619},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.2290949821472168},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22003179788589478},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.19808536767959595},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1078261137008667},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.82.10_supplement.p2.262","doi":"https://doi.org/10.1212/wnl.82.10_supplement.p2.262","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.82.10_supplement.p2.262","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.6800000071525574,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2339704287","https://openalex.org/W1804218589","https://openalex.org/W1549346998","https://openalex.org/W13683457","https://openalex.org/W2200418928","https://openalex.org/W4389467217","https://openalex.org/W2551637194","https://openalex.org/W7056405741","https://openalex.org/W3011839020","https://openalex.org/W2231509777"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"establish":[2],"the":[3,17,31,37,43,118,126,138,157,163,196,225,301,309],"potential":[4],"for":[5,94,102,144,179],"BIIB033,":[6],"a":[7,73,92,98,285],"monoclonal":[8],"antibody":[9],"to":[10,30,116,172,182,299],"LINGO-1,":[11],"as":[12],"axonal":[13,81,112,189,245,255,282,291],"protective":[14,119,265],"therapy":[15],"in":[16,87,97,125,233,239,267,284,308],"visual":[18],"system.":[19],"BACKGROUND:":[20],"Acute":[21],"optic":[22,38,106,187,226,268,289],"neuritis":[23],"(AON)":[24],"is":[25,41,72,297],"characterized":[26],"by":[27,215],"inflammatory":[28],"damage":[29],"myelin":[32],"sheath":[33],"and":[34,40,64,146,213,247,270],"axons":[35,152],"comprising":[36],"nerve":[39,53,107,188,227,269,290],"frequently":[42],"first":[44,197],"manifestation":[45],"of":[46,51,75,111,121,128,150,199,207,249,276,288,304],"MS.":[47],"In":[48,224],"humans,":[49],"and~20%":[50],"retinal":[52,208],"fibers":[54,212],"are":[55,169,203],"lost":[56],"after":[57,306],"an":[58],"AON":[59,307],"episode.":[60],"LINGO-1":[61,84,132,230,253,280],"(leucine-rich":[62],"repeats":[63],"immunoglobulin":[65],"domain-containing":[66],"neurite":[67],"outgrowth":[68],"inhibitor":[69],"receptor-interacting":[70],"protein-1)":[71],"component":[74],"CNS":[76],"signaling":[77],"complexes":[78],"that":[79,153],"suppress":[80],"repair/remyelination.":[82],"Blocking":[83,252,279],"improves":[85],"remyelination":[86],"animal":[88],"models,":[89],"thereby":[90],"providing":[91],"rationale":[93],"evaluating":[95],"BIIB033":[96,173,185,305],"Phase":[99,294],"2":[100,295],"study":[101,296],"AON.":[103,201],"DESIGN/METHODS:":[104],"The":[105,148,259],"crush":[108,139,158,228],"rat":[109,286],"model":[110,287],"degeneration":[113,190,236,246],"was":[114,133,142,160,231,237],"used":[115],"investigate":[117],"role":[120],"anti-LINGO-1":[122],"(or":[123],"vehicle)":[124],"absence":[127],"autoimmune":[129],"inflammation.":[130],"Anti":[131],"given":[134,192],"intravitreally":[135],"or":[136,174],"at":[137],"site.":[140],"Tissue":[141],"processed":[143],"visualization":[145],"quantification.":[147],"length":[149],"labeled":[151],"had":[154],"regrown":[155],"beyond":[156],"site":[159],"measured.":[161],"For":[162],"clinical":[164,260],"trial,":[165],"eligible":[166],"individuals":[167],"(N=80)":[168],"being":[170],"randomized":[171],"placebo":[175],"every":[176],"4":[177],"weeks":[178,181],"20":[180],"assess":[183],"whether":[184,264],"prevents":[186],"when":[191],"<28":[193],"days":[194],"before":[195],"episode":[198],"unilateral":[200],"Participants":[202],"undergoing":[204],"serial":[205],"measurements":[206],"ganglion":[209],"cell":[210],"(RGC)":[211],"layers":[214],"spectral":[216],"domain":[217],"optical":[218],"coherence":[219],"tomography":[220],"(ClinicalTrials.gov":[221],"#NCT01721161).":[222],"RESULTS:":[223],"study,":[229],"expressed":[232],"RGCs.":[234],"Axonal":[235],"reduced":[238],"anti-LINGO-1-treated":[240],"rats;":[241],"vehicle-treated":[242],"rats":[243],"showed":[244],"collapse":[248],"RGC":[250],"fibers.":[251],"induced":[254],"regeneration":[256,283],"versus":[257],"controls.":[258],"trial":[261],"will":[262],"determine":[263],"effects":[266],"RGCs":[271],"occur":[272],"using":[273],"systemic":[274],"administration":[275],"BIIB033.":[277],"CONCLUSIONS:":[278],"improved":[281],"injury.":[292],"A":[293],"underway":[298],"examine":[300],"neuroprotective":[302],"efficacy":[303],"clinic.":[310],"Study":[311],"Supported":[312],"by:":[313],"Biogen":[314],"Idec":[315]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}